980 A randomized phase 2 study evaluating the optimal sequencing of sipuleucel-T and androgen deprivation therapy (ADT) in biochemically-recurrent prostate cancer (BRPC): Immune results with a focus on humoral responses

✍ Scribed by Antonarakis, E.S.; Kibel, A.S.; Adams, G.W.; Karsh, L.I.; Elfiky, A.; Shore, N.D.; Vogelzang, N.J.; Corman, J.M.; Tyler, R.C.; McCoy, C.; DeVries, T.; Sheikh, N.; Drake, C.G.

• Book ID: 122977071
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 202 KB
• Volume: 13
• Category: Article
• ISSN: 1569-9056
• DOI: 10.1016/S1569-9056(14)60964-7